The University of Texas at Arlington
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, The University of Texas at Arlington sits in the top decile of US sponsors by registered trial count (#513 of 15,742 sponsors by registered trial count).
The University of Texas at Arlington: 32 sponsored US clinical trials, 11 recruiting.
The University of Texas at Arlington sponsors 32 registered US clinical trials on ClinicalTrials.gov, 11 of them currently recruiting, and 20 completed. 2 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Aging, with 2 trials.
Top-decile sponsor footprint
The University of Texas at Arlington ranks in the top decile of sponsors by registered trial count (#513 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
20 of 21 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (95.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
32 total, page 1 of 1
Virtual Reality Lethal Means Safety Training
NCT07219355
Using Near-Infrared Light to Better Understand Peripheral Artery Disease
NCT07313410
Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) Study
NCT07196436
Arlington Aging Study
NCT06857877
Black Women's Life Experience On Cardiovascular Health Via Ongoing Monitoring
NCT06150989
Reducing Blood Pressure in Mid-life Adult Binge Drinkers
NCT05522075
Exploring Virtual Reality Adventure Training Exergaming
NCT05563805
Effects of Exercise and Virtual Reality on Depression
NCT05973461
Virtual Reality-Infused Treadmill Training on Aging-Related Outcomes
NCT06727942
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
NCT03471117
L-arginine to Reduce Sympathetic Nerve Activity in CKD Patients
NCT03982160
Brain Vascular and Neurocognitive Health
NCT06497413
The Acute Effect of and Energy Drink vs. Water Consumption on MAP, HR, and Energy Metabolism
NCT06330649
The Impact of Goode Health Beverage on Markers of Physiological and Neurocognitive Health
NCT06245382
The Impact of KETO5 XOGenius Beverage on Markers of Physiological and Neurocognitive Health
NCT06318390
Partnership in Resilience for Medication Safety (PROMIS)
NCT05880368
Know and Own Your Movement-related Metrics Via Wearable Devices
NCT05490641
Peanuts and Neurocognitive / Cardiovascular Health in Black Individuals
NCT06318377
Effect of Waterpipe Size on Smoking Behavior and Exposures
NCT05705375
Intergenerational Reminiscence and Digital Storytelling
NCT05984732
Improving the Mobility of Transportation Disadvantaged Older Adults
NCT05812105
Impact of a Plant-Based Diet on Indices of Cardiovascular Health in African Americans
NCT05344287
The Senior Companion Program Plus
NCT03602391
Local Antioxidant Therapy Vasoconstriction Effects in Different Races
NCT03684213
The Effect of Endothelin and L-Arginine on Racial Differences in Vasoconstriction
NCT03679780
The Effect of Local Antioxidant Therapy on Racial Differences in Vasoconstriction
NCT03680404
The Effect of Antioxidants on Skin Blood Flow-BH4
NCT03680573
Transcranial Infrared Laser Stimulation (TILS) of Prefrontal Cognition in Post-traumatic Stress Disorder (PTSD)
NCT03209882
Mechanisms and Management of Exercise Intolerance in Older Heart Failure Patients
NCT03111017
The Effect of Antioxidants on Skin Blood Flow During Local Heating
NCT03680638
Treatment of Post-Traumatic Stress Disorder (PTSD) and Chronic Pain After Traumatic Orthopedic Injury
NCT00957164
An Implementation and Biobehavioral Study of Temporomandibular Joint and Muscle Disorder (TMJMD)
NCT00952900
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 4 | 2 |
What is open in the The University of Texas at Arlington pipeline
11 recruiting of 32 indexed (34% open); 20 completed (63%).
Phase mix: 2 late (III/IV) vs 5 early (I/II) (early-phase heavy).
Top condition: Aging (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
The University of Texas at Arlington: open-pipeline peers nationwide
Peers matched on 32 registered trials and 34% open enrollment, not the therapeutic-area sidebar.
The University of Texas at Arlington sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 32 trials (± recruiting share)
- Aerie Pharmaceuticals · 32 trials · 0% recruiting
- Allina Health System · 32 trials · 3% recruiting
- Ardea Biosciences · 32 trials · 0% recruiting
- Hebrew SeniorLife · 32 trials · 19% recruiting
Sponsors near 34% open enrollment (± trial volume)
- New York Medical College · 34% recruiting · 47 trials
- The Hospital for Sick Children · 35% recruiting · 23 trials
- Giselle Sholler · 35% recruiting · 20 trials
- Stemline Therapeutics · 35% recruiting · 17 trials
Related
What to do with this The University of Texas at Arlington page
32 registered trials is a research-attention snapshot, not an endorsement of The University of Texas at Arlington or any single study.
- 11 of The University of Texas at Arlington's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Aging is the condition The University of Texas at Arlington studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Aging trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
The University of Texas at Arlington pipeline card: 32 registered trials from official public datasets.Report a data error.